Ocular decompression with cotton swabs lowers intraocular pressure elevation after intravitreal injection

Journal of Glaucoma

Volumn 23, Issue 8, 2014, Pages 508-512

  Gregori, Ninel Z ^a,b   Weiss, Matthew J ^b   Goldhardt, Raquel ^a,b   Schiffman, Joyce C ^b   Vega, Edgardo ^a   Mattis, Cherrie Ann ^a   Shi, Wei ^b   Kelley, Linda ^a   Hernandez, Vilma ^a   Feuer, William J ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Anti VEGF agent; Eye decompression; Intraocular pressure; Intravitreal injection

Indexed keywords

LIDOCAINE; RANIBIZUMAB; GEL; LOCAL ANESTHETIC AGENT; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COTTON SWAB; DECOMPRESSION; FEMALE; GEL; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; INTRAOCULAR PRESSURE ABNORMALITY; MALE; OCULAR DECOMPRESSION; OPHTHALMOLOGICAL EQUIPMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VERY ELDERLY; ADMINISTRATION AND DOSAGE; DECOMPRESSION SURGERY; DEVICES; EYE DISEASES; INTRAVITREAL DRUG ADMINISTRATION; LOCAL ANESTHESIA; MIDDLE AGED; PAIN; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

ADULT; AGED; AGED, 80 AND OVER; ANESTHESIA, LOCAL; ANESTHETICS, LOCAL; ANTIBODIES, MONOCLONAL, HUMANIZED; DECOMPRESSION, SURGICAL; EYE DISEASES; FEMALE; GELS; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; LIDOCAINE; MALE; MIDDLE AGED; PAIN; PROSPECTIVE STUDIES;

EID: 84916604489     PISSN: 10570829     EISSN: 1536481X     Source Type: Journal    
DOI: 10.1097/IJG.0b013e318294865c     Document Type: Article

References (19)

1. Stewart MW, Rosenfeld PJ, Penha FM, et al. Pharmacokinetic rationale for dosing every 2 weeks versus 4 weeks with intravitreal ranibizumab, bevacizumab, and aflibercept (vascular endothelial growth factor Trap-eye). Retina. 2012;32: 434-457.
2. Falkenstein IA, Cheng L, Freeman WR. Changes of intraocular pressure after intravitreal injection of bevacizumab (avastin). Retina. 2007;27: 1044-1047.
3. Sharei V, Hohn F, Kohler T, et al. Course of intraocular pressure after intravitreal injection of 0.05mL ranibizumab (Lucentis). Eur J Ophthalmol. 2010;20: 174-179.
4. Kim JE, Mantravadi AV, Hur EY, et al. Short-Term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents. Am J Ophthalmol. 2008;146: 930-934 e1.
5. Gismondi M, Salati C, Salvetat ML, et al. Short-Term effect of intravitreal injection of ranibizumab (Lucentis) on intraocular pressure. J Glaucoma. 2009;18: 658-661.
6. Hollands H, Wong J, Bruen R, et al. Short-Term intraocular pressure changes after intravitreal injection of bevacizumab. Can J Ophthalmol. 2007;42: 807-811.
7. Riva CE, Hero M, Titze P, et al. Autoregulation of human optic nerve head blood flow in response to acute changes in ocular perfusion pressure. Graefes Arch Clin Exp Ophthalmol. 1997;235: 618-626.
8. Yan DB, Coloma FM, Metheetrairut A, et al. Deformation of the lamina cribrosa by elevated intraocular pressure. Br J Ophthalmol. 1994;78: 643-648.
9. Mathalone N, Arodi-Golan A, Sar S, et al. Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2012;250: 1435-1440.
10. Aref AA. Management of immediate and sustained intraocular pressure rise associated with intravitreal antivascular endothelial growth factor injection therapy. Curr Opin Ophthalmol. 2012;23: 105-110.
11. Hoang QV, Mendonca LS, Della Torre KE, et al. Effect on intraocular pressure in patients receiving unilateral intravitreal anti-vascular endothelial growth factor injections. Ophthalmology. 2012;119: 321-326.
12. Kim KS, Jee D. Effect of the Honan intraocular pressure reducer on intraocular pressure increase following intravitreal injection using the tunneled scleral technique. Jpn J Ophthalmol. 2011;55: 632-637.
13. Gregori NZ, Weiss MJ, Goldhardt R, et al. Randomized clinical trial of two anesthetic techniques for intravitreal injections: 4% liquid lidocaine on cotton swabs versus 3.5% lidocaine gel. Expert Opin Drug Deliv. 2012;9: 735-741.
14. Good TJ, Kimura AE, Mandava N, et al. Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents. Br J Ophthalmol. 2011;95: 1111-1114.
15. Adelman RA, Zheng Q, Mayer HR. Persistent ocular hypertension following intravitreal bevacizumab and ranibizumab injections. J Ocul Pharmacol Ther. 2010;26: 105-110.
16. Kahook MY, Kimura AE, Wong LJ, et al. Sustained elevation in intraocular pressure associated with intravitreal bevacizumab injections. Ophthalmic Surg Lasers Imaging. 2009;40: 293-295.
17. Tseng JJ, Vance SK, Della Torre KE, et al. Sustained increased intraocular pressure related to intravitreal antivascular endothelial growth factor therapy for neovascular age-related macular degeneration. J Glaucoma. 2012;21: 241-247.
18. Morrison JC, TS A. Anatomy and Physiology of Aqueous Humor Outflow. In: Glaucoma -Science and Practice. New York: Thieme Medical Publishers Inc; 2003: 34-41.
19. Goldmann H. [Out-flow pressure, minute volume and resistance of the anterior chamber flow in man]. Doc Ophthalmol. 1951;5-6: 278-356.